Financial Architects, Inc - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 22 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Financial Architects, Inc ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$18,000
-28.0%
2,7500.0%0.00%0.0%
Q4 2017$25,000
-7.4%
2,7500.0%0.00%
-20.0%
Q3 2017$27,000
+68.8%
2,750
+37.5%
0.01%
+66.7%
Q2 2017$16,000
+33.3%
2,0000.0%0.00%
+50.0%
Q1 2017$12,0000.0%2,0000.0%0.00%
-33.3%
Q4 2016$12,000
-20.0%
2,0000.0%0.00%
-25.0%
Q3 2016$15,000
-48.3%
2,000
-42.0%
0.00%
-50.0%
Q2 2016$29,0003,4500.01%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 290,501$2,513,0001.83%
Knoll Capital Management, LLC 20,000$173,0000.11%
Private Portfolio Partners LLC 42,250$365,4630.09%
Rossmore Private Capital 40,661$352,0000.06%
OCCUDO QUANTITATIVE STRATEGIES LP 54,233$469,0000.04%
Cubist Systematic Strategies, LLC 241,892$2,092,0000.02%
TWO SIGMA ADVISERS, LP 662,000$5,726,0000.02%
TWO SIGMA INVESTMENTS, LP 550,956$4,766,0000.01%
Jump Financial, LLC 34,800$301,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 264,824$2,291,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders